66 results
8-K
EX-99.1
NMRD
Nemaura Medical Inc
21 Nov 23
Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth
8:38am
on the Nasdaq, Nemaura Medical has proactively pursued a funding strategy that minimizes dilution and, the Company believes, aligns with the best interests of its
424B8
NMRD
Nemaura Medical Inc
11 Sep 23
Prospectus unintentially filed late
4:41pm
programs; our future opportunities; our business strategy, future operations, anticipated financial position, future revenues and projected costs; our … ),” “predict(s),” “strategy,” “will,” “expect(s),” “estimate(s),” “anticipate(s),” “believe(s),” “project(s),” “intend(s),” “plan(s),” “budget(s
PRE 14A
zcsdc
10 Aug 23
Preliminary proxy
4:05pm
POS AM
v38cq9h
3 Aug 23
Prospectus update (post-effective amendment)
4:08pm
424B4
ucpibomg9z6q nn2nx2
15 May 23
Prospectus supplement with pricing info
4:31pm
CORRESP
r1kx4u9gjtpeti06j0
10 May 23
Correspondence with SEC
12:00am
8-K
EX-99.1
aibv9
14 Nov 22
Nemaura Medical Reports Fiscal Second Quarter 2023 Results and Provides Business Update
5:21pm
8-K
ri75mhc0fkzk dg
8 Jul 22
Departure of Directors or Certain Officers
4:05pm
424B5
ekgkw9o0axsj
1 Apr 22
Prospectus supplement for primary offering
4:29pm